The impact of pharmacogenetics for migraine

European Journal of Pharmacology

Volumn 413, Issue 1, 2001, Pages 1-10

  Ophoff, Roel A ^a   Van den Maagdenberg, Arn M J M ^a   Roon, Krista I ^a   Ferrari, Michel D ^a   Frants, Rune R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Ca2+ channel; CACNA1A; Migraine; Pharmacogenetics; Triptan

Indexed keywords

CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; SEROTONIN ANTAGONIST;

ANIMAL MODEL; CHROMOSOME 19P; CLINICAL FEATURE; HEADACHE; HUMAN; MIGRAINE; MOUSE; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CHROMOSOMES, HUMAN, PAIR 19; ERGOT ALKALOIDS; HUMANS; MIGRAINE DISORDERS; MUTATION; PHARMACOGENETICS; RECEPTORS, DOPAMINE D2; SUMATRIPTAN; VALPROIC ACID;

EID: 0035830644     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00949-3     Document Type: Review

References (61)

1. A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia
2. 1B receptor
3. Genetic heterogeneity in Italian families with familial hemiplegic migraine
4. Sodium channel defects in myotonia and periodic paralysis
5. Association between dopamine receptor genes and migraine without aura in a Sardinian sample
6. A practical guide to the management and prevention of migraine
7. The D2 receptor NcoI allele: Absence of allelic association with migraine with aura
8. Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity
9. Recurrence of the T666M calcium channel CACNA1A gene mutation in familial hemiplegic migraine with progressive cerebellar ataxia
10. Characterization of CACNA1A mutations in familial and sporadic hemiplegic migraine
11. Serotonin metabolism in migraine
12. Neuroexcitatory plasma amino acids are elevated in migraine
13. Treatment of migraine attacks with sumatriptan
14. Migraine
15. Clinical and experimental effects of sumatriptan in humans
16. 5-HT1 receptors in migraine pathophysiology and treatment
17. Absence epilepsy in tottering mutant mice is associated with calcium channel defects
18. A new locus for hemiplegic migraine maps to chromosome 1q31
19. Migraine without aura: A population-based twin study
20. How do the currently used prophylactic agents work in migraine?
21. Treatment of severe, disabling migraine attacks in over-the-counter population of migraine sufferers: Results from three randomized, placebo-controlled studies of the combination of acetaminophen, aspirin, and caffeine
22. Familial hemiplegic migraine in The Netherlands
23. Functional consequences of mutations in the human alpha1A calcium channel subunit linked to familial hemiplegic migraine
24. Familial migraine: Exclusion of the susceptibility gene from the reported locus of familial hemiplegic migraine on 19p
25. The skeletal muscle sodium and chloride channel diseases
26. Serotonin and migraine
27. Genetic heterogeneity of familial hemiplegic migraine
28. Effect of serotonin in migraine patients
29. 2+ channel kinetics
30. Three new familial hemiplegic migraine mutants affect P/Q-type Ca(2+) channel kinetics
31. 2C)
32. Prevalence and impact of migraine
33. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: Three double-blind, randomized, placebo-controlled trials
34. Altered calcium channel currents in Purkinje cells of the neurological mutant mouse leaner
35. 1B receptor polymorphisms and clinical response to sumatriptan
36. Human coronary artery contraction to sumatriptan: A post hoc analysis
37. Familial hemiplegic migraine locus on 19p13 is involved in the common forms of migraine with and without aura
38. The use of single-nucleotide polymorphism maps in pharmacogenomics
39. Side effects of ergotamine
40. Molecular genetics of migraine headaches: A review
41. 2+ channels is associated with the ataxic mouse mutation rolling Nagoya (tg(rol))
42. Genetic heterogeneity of familial hemiplegic migraine
43. 2+ channel gene CACNL1A4
44. Dopamine and migraine
45. Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles
46. Serotonin receptor variants in disease: New therapeutic oppurtunities?
47. Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles
48. Abnormal transmitter release at neuromuscular junctions of mice carrying the tottering alpha(1A) Ca(2+) channel mutation
49. Presynaptic Ca(2+) influx at a mouse central synapse with Ca(2+) channel subunit mutations
50. Inheritance of migraine investigated by complex segregation analysis
51. A nosographic analysis of the migraine aura in a general population
52. Methysergide
53. The quest for migraine genes
54. Intramuscular ergotamine: Plasma levels and dynamic activity
55. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine
56. Calcium antagonists in migraine prophylaxis
57. Sporadic hemiplegic migraine with de novo CACNA1A missense mutation
58. Chest symptoms after sumatriptan: A two-years clinical practice review in 735 consecutive migraine patients
59. Single tottering mutations responsible for the neuropathic phenotype of the P-type calcium channel
60. Population choice in mapping genes for complex diseases
61. Migraine in twins raised together and apart